Episode Details
Back to Episodes
Pharmaceutical Executive Daily: FDA Approves Three New Therapies
Published 2 days, 1 hour ago
Description
FDA approves three new therapies, a wave of dealmaking led by Johnson & Johnson, Eli Lilly, AmyriAD Therapeutics, and Sanofi, and Ossium Health’s Kevin Caldwell joins The Ron Lanton Report on rebuilding bone marrow transplants around deceased-donor marrow.